A Randomized Trial Evaluating a mRNA-VLP vaccine’s Immunogenicity and Safety for COVID-19

Trial Identifier: D8670C00001
Sponsor: AstraZeneca
NCTID:: NCT06147063
Start Date: November 2023
Primary Completion Date: May 2024
Study Completion Date: April 2025
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Long Beach, CA, US, 90815
US, CA Rolling Hills Estates, CA, US, 90274
US, IL Chicago, IL, US, 60640
US, KS Wichita, KS, US, 67207
US, South Carolina North Charleston, South Carolina, US, 29405